Consolidated Statement of Cash Flows (USD $) In Thousands	9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Cash flows from operating activities:
Net income/(loss) attributable to the Company	$ 26,075	$ (1,012)
Adjustments to arrive at net income from continuing operations [Abstract]
Net income attributable to noncontrolling interests	2,313	1,929
Net (income)/loss from discontinued operations	(4,752)	(1,812)
Net income/(loss) from continuing operations	23,636	(895)
Adjustments to reconcile net income/(loss) from continuing operations to net cash provided by/(used in) operating activities:
Depreciation and amortization	14,359	13,073
Net income attributable to noncontrolling interests	(2,313)	(1,929)
Equity issued as compensation	4,869	4,367
Provision for loan losses	15,660	54,627
Loans originated for sale	(93,281)	(153,622)
Proceeds from sale of loans held for sale	89,522	145,022
Gain on the repurchase of debt	(1,838)	0
Decrease/(increase) in income tax receivable and deferred	6,755	(29,147)
Net decrease/(increase) in other operating activities	766	2,436
Net cash provided by/(used in) operating activities of continuing operations	58,135	33,932
Net cash provided by/(used in) operating activities of discontinued operations	4,752	1,812
Net cash provided by/(used in) operating activities	62,887	35,744
Investment securities available for sale:
Purchases	(555,990)	(570,834)
Sales	131,041	407,515
Maturities, redemptions, and principal payments	375,311	315,970
Purchases	0	(5,993)
Maturities, sales, and principal payments	0	7,489
(Investments)/distributions in trusts, net	231	(130)
(Purchase)/ redemption of Federal Home Loan Banks stock	1,598	1,097
Net (increase)/ decrease in portfolio loans	(33,351)	(273,449)
Proceeds from sale of OREO	18,277	10,450
Proceeds from sale of portfolio loans	0	18,434
Proceeds from sale and repayments of non-strategic loan portfolio	1,000	276
Capital expenditures, net of sale proceeds	(6,864)	(2,937)
Cash received from dispositions/ (paid for acquisitions, including deferred acquisition obligations, net of cash acquired)	586	(29,691)
Net cash provided by/(used in) investing activities	(68,161)	(121,803)
Cash flows from financing activities:
Net increase in deposits	47,350	237,297
Net (decrease)/increase in securities sold under agreements to repurchase and other	(150,304)	(134,802)
Net (decrease)/increase in short-term Federal Home Loan Bank borrowings	(10,000)	0
Advances of long-term Federal Home Loan Bank borrowings	104,313	166,040
Repayments of long-term Federal Home Loan Bank borrowings	(142,514)	(136,531)
Repurchase of debt	(3,000)	0
Net proceeds from issuance/ (paid for repurchase) of Series C Preferred stock	0	(154,000)
Dividends paid to common stockholders	(2,314)	(2,139)
Dividends paid to preferred stockholders	(218)	(3,027)
Tax deficiency from certain stock compensation awards	(1,582)	(1,206)
Proceeds from stock option exercises	181	465
Proceeds from issuance of common stock, net	1,244	34,081
Other equity adjustments	(1,896)	3,903
Net cash provided by/(used in) financing activities	(158,740)	10,081
Net increase/(decrease) in cash and cash equivalents	(164,014)	(75,978)
Cash and cash equivalents at beginning of year	494,439	447,460
Cash and cash equivalents at end of period	330,425	371,482
Supplementary schedule of non-cash investing and financing activities:
Cash paid for interest	39,318	56,274
Cash paid for income taxes, net of (refunds received)	11,407	21,135
Change in unrealized gain/ (loss) on securities available for sale, net of tax	3,680	1,106
Change in unrealized gain/ (loss) on cash flow hedges, net of tax	(1,869)	(3,235)
Change in unrealized gain/ (loss) on other, net of tax	316	2
Held to maturity investments transferred to available for sale or other investments at amortized cost	2,515	0
Loans transferred into other real estate owned from held for sale or portfolio	10,202	9,131
Loans transferred into/(out of) held for sale from/(to) portfolio	(526)	18,360
Equity issued for acquisitions, including deferred acquisition obligations	$ 4,290	$ 3,303